glp 1 drugs semaglutide Blockbuster GLP-1 Diabetes and Weight Loss Fails in Alzheimer's Trial GLP-1s | AgelessRx

Semaglutide is often just one part of a bigger care plan focused on improving overall wellness

Semaglutide Side Effects Adverse events from the SUSTAIN (type 2 diabetes) and STEP (weight management) trials, summarised on the Ozempic and Wegovy FDA prescribing labels, are predominantly gastrointestinal and most pronounced during titration

The glucagon receptor is the new piece, and it is the one I am paying the most attention to

This concern is particularly relevant for patients with stricturing CD, in whom up to 50% develop fibrostenotic complications within 10 years of diagnosis (74)

For more details, see Ozempics prescribing information

1-6 In some people, complications are more likely to occur at higher doses, even under medical supervision